共查询到20条相似文献,搜索用时 0 毫秒
1.
Hirofumi Uto Katsuhiro Hayashi Kazunori Kusumoto Satoru Hasuike Kenji Nagata Mayumi Kodama Akio Ido Michinori Kohara Sherri O Stuver Hirohito Tsubouchi 《Hepatology research》2006,34(1):28-34
The natural course of hepatitis C virus (HCV) carriers is not well understood. We examined the clinical characteristics of individuals exhibiting spontaneous elimination of HCV as part of a cohort study of residents of a HCV hyperendemic area in Japan. In individuals who were judged to have persistent HCV infection in 1995, 302 had at least 4 annual ALT measurements between 1993 and 2000, and had not been treated with IFN. They were tested for the presence of HCV RNA in 2001 and/or 2002 and HCV RNA could not be detected in 20 of the 302 individuals. In these 20 individuals, 7 were confirmed to have detectable HCV RNA and 13 were not until 2000. Thus, 2.4% (7/289) were judged to have spontaneously eliminated the HCV infection during that 6-year period. Although there were no differences in age, sex, ALT levels, or serologically defined HCV genotype between individuals with and without exhibiting spontaneous elimination, there was a significant relationship between the elimination of HCV RNA and a low level of HCVcAg (<20pg/mL) (P<0.001) upon testing in 1995. These results suggest that spontaneous elimination of HCV RNA following persistent infection is rare and appears to be related to viral load. 相似文献
2.
3.
探讨联合检测血清HBV前s1抗原(preSl)和核心抗原(HBcAg)(均为HBV核酸相关抗原,nucleic acids related antigen,HBV NRAg)的意义及临床价值。方法:采用ELISA法对393份HBsAg、HBV DNA双阳性的血清和612份HBsAg阴性血清进行HBV NRAg检测,所有标本均采用多区段巢式PCR确认阳性、阴性,采用荧光定量PCR法进行HBV DNA定量分析。结果:393份HBsAg、HBV DNA双阳性血清中,HBV NRAg阳性为382份,其阳性率为97.2%;612份HBsAg阴性的血清标本中,609份确认为HBV DNA阴性,其中检出2份HBV NRAg阳性,607份为阴性,其HBV NRAg的阴性率为99.7%(607/609),另3份HBsAg阴性血清HBV DNA阳性者,其HBV NRAg均为阳性。结论:联合检测preSl和HBcAg的HBV NRAg可作为临床HBV感染的筛选及判断HBV复制的有意义的补充项目。 相似文献
4.
Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China 总被引:1,自引:0,他引:1
Zhang HQ Li SB Wang GH Chen K Song XG Feng XY 《World journal of gastroenterology : WJG》2007,13(19):2738-2742
AIM: To evaluate the effi cacy of a new hepatitis C virus (HCV) core antigen assay developed in China. METHODS: After the determination of HCV infection, 49 serial samples were selected from 11 regular plasma donors in 5 different plasma stations. To compare the performance of HCV core antigen detection and HCV PCR, these samples were genotyped, and each specimen was analyzed by ELISA for the detection of HCV core antigen and by qualitative HCV PCR. RESULTS: Among all of the sequential samples, the original 13 specimens were HCV RNA-negative, and 36 samples were HCV RNA-positive. Twenty-seven samples (75%) were HCV core antigen-positive from these HCV RNA-positive specimens. Conversely, 27 samples (93.1%) were found HCV RNA-positive in HCV core antigen-positive samples. Intervals between HCV RNA and HCV core antigen-positive, as well as between HCV core antigen-positive and HCV antibody-positive were 36.0 and 32.8 d, respectively. CONCLUSION: This HCV core antigen assay, developed in China, is able to detect much of anti-HCV-negative, HCV RNA-positive preseroconversion window period (PWP) plasma donations. 相似文献
5.
Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection 总被引:6,自引:0,他引:6
Suzuki S Tanaka Y Orito E Sugauchi F Hasegawa I Sakurai M Fujiwara K Ohno T Ueda R Mizokami M 《Journal of gastroenterology and hepatology》2003,18(10):1139-1143
BACKGROUND AND AIM: Transforming growth factor beta-1 (TGF-beta1) is one of the most dominant fibrogenic cytokines in hepatic fibrosis. The aim of the present study was to examine the effects of TGF-beta1 polymorphisms in Japanese patients with chronic hepatitis C virus (HCV) infection and in healthy control subjects. METHODS: The TGF-beta1 genotypes at codon 10 and codon 25 were determined in 206 Japanese patients with chronic HCV infection and in 101 Japanese healthy control subjects. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used for the detection of these polymorphisms. The degree of hepatic fibrosis was assessed by liver biopsy and graded according to the New Inuyama Classification for chronic hepatitis graded F0-4. RESULTS: The authors found no significant differences in genotype distributions and allele frequency between the HCV patients and the healthy control subjects. The frequencies of the TT, TC, and CC genotypes of codon 10 were 24%, 42% and 35%, respectively, among the patients of the F0-2 group, and 31%, 40% and 29%, respectively, among those of the F3-4 group. No significant differences were shown between the TGF-beta1 polymorphism at codon 10 and the stage of hepatic fibrosis. In contrast, no genetic alteration of codon 25 was found in healthy controls and patients with chronic HCV infection. CONCLUSION: These results suggest that there may not be a significant relationship between polymorphism at codon 10 and the development of progressive hepatic fibrosis in the Japanese population. 相似文献
6.
Beth Catlett Francois M. J. Lamoury Sahar Bajis Behzad Hajarizadeh Danica Martinez Yasmin Mowat Philip H. Cunningham Brendan P. Jacka Gavin A Cloherty Philippa Marks Gregory J. Dore Jason Grebely Tanya L. Applegate 《Journal of viral hepatitis》2019,26(12):1423-1430
The global scale‐up of hepatitis C virus (HCV) diagnosis requires simplified and affordable HCV diagnostic pathways. This study evaluated the sensitivity and specificity of the HCV Architect core antigen (HCVcAg) assay for detection of active HCV infection in plasma and capillary whole blood dried blood spots (DBS) compared with HCV RNA testing in plasma (Abbott RealTime HCV Viral Load). Samples were collected from participants in an observational cohort enrolled at three sites in Australia (two‐drug treatment and alcohol clinics and one homelessness service). Of 205 participants, 200 had results across all samples and assay types and 186 were included in this analysis (14 participants receiving HCV therapy were excluded). HCV RNA was detected in 29% of participants ([95% CI: 22.6‐36.1], 54 of 186). The sensitivity of HCVcAg for detection of active HCV infection in plasma was 98.1% (95% CI: 90‐100) and 100% (95% CI: 93‐100) when compared to HCV RNA thresholds of ≥12 and ≥1000 IU/mL, respectively. The sensitivity of the HCVcAg assay for detection of active HCV infection in DBS was 90.7% (95% CI: 80‐97) and 92.5% (95% CI: 82‐98) when compared to HCV RNA thresholds of ≥12 and ≥1000 IU/mL, respectively. The specificity of HCV core antigen for detection of active infection was 100% (95% CI: 97‐100) for all samples and RNA thresholds. These data indicate that the detection of HCVcAg is a useful tool for determining active HCV infection; to facilitate enhanced testing, linkage to care and treatment particularly when testing plasma samples are collected by venepuncture. 相似文献
7.
Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C 总被引:7,自引:0,他引:7
Huang H Shiffman ML Cheung RC Layden TJ Friedman S Abar OT Yee L Chokkalingam AP Schrodi SJ Chan J Catanese JJ Leong DU Ross D Hu X Monto A McAllister LB Broder S White T Sninsky JJ Wright TL 《Gastroenterology》2006,130(6):1679-1687
BACKGROUND & AIMS: Previously identified clinical risk factors such as sex, alcohol consumption, and age at infection do not accurately predict which patients with chronic hepatitis C (CHC) will develop advanced fibrosis (bridging fibrosis and cirrhosis). The aim of this study was to identify genetic polymorphisms that can predict the risk of advanced fibrosis in patients with CHC. METHODS: A total of 916 subjects with CHC was enrolled from 2 centers. A gene-centric disease association study of 24,832 putative functional, single nucleotide polymorphisms (SNPs) was performed. Of the 1609 SNPs that were significantly associated (P = .05) with advanced fibrosis in the discovery cohort (University of California San Francisco [UCSF], N = 433), the first batch of 100 SNPs were selected for validation in the replication cohort (Virginia Commonwealth University [VCU], N = 483). RESULTS: A missense SNP in the DEAD box polypeptide 5 (DDX5) gene was significantly associated with an increased risk of advanced fibrosis in both the UCSF and the VCU cohorts (OR, 1.8 and 2.2, respectively). Two diplotype groups, carrying the haplotypes composed of the DDX5 SNP and 2 neighboring POLG2 SNPs were also significantly associated with an increased risk of advanced fibrosis and had comparable or better risk estimates. In addition, a missense SNP in the carnitine palmitoyltransferase 1A (CPT1A) gene was associated with a decreased risk of advanced fibrosis in both the UCSF and the VCU cohorts (OR, 0.3 and 0.6, respectively). CONCLUSIONS: Subjects with CHC carrying DDX5 minor allele or DDX5-POLG2 haplotypes are at an increased risk of developing advanced fibrosis, whereas those carrying the CPT1A minor allele are at a decreased risk. 相似文献
8.
High molecular weight form of adiponectin levels of Japanese patients with chronic hepatitis C virus infection 总被引:1,自引:0,他引:1
Norihiro Furusyo Yasunori Sawayama Shinji Maeda Kazuhiro Toyoda Hiroaki Takeoka Masayuki Murata Hachiro Ohnishi Jun Hayashi 《Hepatology research》2007,37(12):1052-1061
Aim: The aim of the present study was to clarify the correlation between serum adiponectin level and the properties of hepatitis C virus (HCV). Methods: A meal test was carried out for insulin resistance assessment in 81 patients with chronic HCV infection. Blood samples were taken before and after the test to measure serum insulin and plasma glucose (PG). The adiponectin level was measured by enzyme-linked immunosorbent assay in each patient. Results: Serum adiponectin levels were significantly correlated with the area under the insulin curve (AUC-insulin)during the meal test and with serum HCV-RNA level. Multiple regression analysis showed age to be a significant independent parameter associated with an increased adiponectin level, whereas male sex, fasting insulin, and serum HCV-RNA level were significant independent parameters associated with a decreased adiponectin level. Conclusion: It is possible that insulin resistance in patients with chronic HCV infection is related to adiponectin secretion. 相似文献
9.
Michio Sata Hitoshi Nakano Hiroshi Suzuki Seiji Noguchi Yohsuke Yamakawa Eisuke Tanaka Kunitaka Fukuizumi Kumi Tanaka Hiroshi Yoshida Kyuichi Tanikawa 《Journal of gastroenterology》1998,33(2):218-222
We conducted an epidemiological study of 509 residents of H town, Fukuoka, Japan, to investigate the high mortality rate
from liver disease. Antibodies to hepatitis C virus (HCV) (anti-HCV) were detected in 120 residents (23.6%); HCV RNA in 91
(17.9%), and hepatitis B surface antigen (HBsAg) in 13 (2.6%). Multivariate logistic regression analyses showed that presence
of anti-HCV, male gender, and history of liver disease were associated with the presence of liver dysfunction, and that age
of more than 40 years and a particular district were associated with the presence of anti-HCV. HCV RNA was more frequently
detected in anti-HCV-positive men than women (41, or 85.4% versus 50, or 69.4%) (P < 0.05). The incidence of liver dysfunction was significantly higher in HCV RNA-positive men than women (32, or 66.7% versus
22, or 30.6%) (P < 0.05). These findings suggest that: (1) HCV was correlated with the high mortality rate from liver diseases, (2) there
were district-related differences in the incidence of HCV, and (3) the lower frequency of elimination of HCV from men may
explain why they showed a high mortality from liver disease.
(Received Mar. 4, 1997; accepted Aug. 22, 1997) 相似文献
10.
González V Padilla E Diago M Giménez MD Solà R Matas L Montoliu S Morillas RM Pérez C Planas R 《Journal of viral hepatitis》2005,12(5):481-487
Summary. Early virological response may predict outcome following treatment with peginterferon alpha-2a and ribavirin in patients chronically infected with hepatitis C virus (HCV). As total HCV core antigen may constitute an alternative direct marker to HCV RNA for assessing the levels of viraemia in such patients, we evaluated the correlation between HCV core antigen and HCV RNA, and whether HCV core antigen at baseline, 4 and 12 weeks after treatment could predict sustained virological response (SVR) to combined therapy, in comparison with HCV RNA. A total of 290 serum samples from 58 previously treatment naïve chronic HCV patients were examined for HCV core antigen and HCV-RNA by means of quantitative HCV RNA when receiving combination therapy for the first time. SVR was significantly associated with basal HCV core antigen but not with HCV RNA. There was a good correlation between HCV core antigen and HCV RNA (r2 = 0.781). The negative predictive value of HCV core antigen testing in predicting nonresponse at weeks 4 and 12 were 75 and 100%, and for undetectable or a 2-log drop in HCV RNA were 69.6 and 75% respectively. HCV core antigen detection is quick, and easy to perform alternative to HCV RNA, and could be used as a marker of HCV viraemia for monitoring the progress of therapy. 相似文献
11.
Yoichi Yano Fumihiko Yamashita Shuji Sumie Kotaro Kuwaki Hiroshi Yamamoto Naoko Toyoda Eiji Ando Masatoshi Tanaka Michio Sata 《Liver international》2003,23(4):227-231
Purpose: We investigated the unsettled issue of whether seropositivity for antibody to hepatitis B core antigen (anti‐HBc) affects characteristics of hepatitis C virus (HCV)‐related hepatocellular carcinoma (HCC). Methods: Antibody status was determined by enzyme immunoassay in 243 patients with this cancer, and associations with clinicopathologic characteristics and outcome were analysed. Serum hepatitis B virus (HBV) DNA was determined by real‐time polymerase chain reaction. Results: Of 235 patients with unequivocal serologic status, 142 were seropositive and 93 were seronegative. Clinicopathologic characteristics and overall cumulative survival rates were comparable between the two groups. However, seropositivity tended to predict poor outcome for patients in Child class B or C (P=0.068), those in tumour‐nodes‐metastasis‐based stage 3 or 4 (P=0.081), those with tumours exceeding 25 mm (P=0.068), and those with a past history of clinical liver disease (P=0.088). Multivariate analysis identified serum albumin, portal vein tumour thrombosis, and tumour size as independent determinants of survival. Serum HBV DNA was below 1.7 log copies/ml in all 40 patients tested. Conclusions: Overall, the clinical features of HCV‐HCC were unaffected by seropositivity for anti‐HBc. Seropositivity tended to worsen prognosis for subgroup with poor hepatic reserve or advanced tumours. 相似文献
12.
13.
Uto H Kurogi J Takahama Y Kusumoto K Hayashi K Ido A Kohara M Stuver SO Moriuchi A Hasegawa S Oketani M Tsubouchi H 《Journal of gastroenterology》2007,42(8):673-680
Background The clinical features of hepatitis C virus (HCV) carriers with persistently normal alanine aminotransferase (PNALT) levels
(ALT ≤ 34 IU/l) have not been fully elucidated. We investigated clinical factors associated with ALT flare-up in PNALT individuals
in a HCV hyperendemic area of Japan.
Methods We analyzed 101 HCV carriers who had PNALT between 1993 and 2000. The first occurrence of ALT flare-up (ALT ≥ 35 IU/l) between
2001 and 2005 was evaluated by the Kaplan-Meier method. Multivariate analysis of factors predicting ALT flare-up were conducted
using Cox proportional hazards models.
Results The mean follow-up period was 2.8 years, and the 5-year cumulative incidence of ALT flare-up was estimated to be 31.8%. In
multivariate analysis, an ALT level of 20–34 IU/l and a high serum ferritin level (≥90 ng/ml) in the most recently available
data up to the year 2000, as well as H63D heterozygosity in the HFE gene, were independently and strongly associated with the incidence of ALT flare-up (Hazard ratios = 5.6, 3.1, and 4.8, respectively).
In addition, HFE H63D heterozygosity was significantly associated with higher serum ferritin levels in subjects with PNALT (153.8 ± 73.3 ng/ml
in subjects with the 63HD genotype vs. 89.4 ± 51.3 ng/ml in subjects with the 63HH genotype, P = 0.043).
Conclusions HCV carriers with PNALT in this population were at risk for ALT flare-up. Basal ALT levels, serum ferritin levels, and HFE polymorphism are potentially important predictors of ALT flare-up. 相似文献
14.
15.
目的 探讨合并HBV感染对慢性HCV感染者血清丙型肝炎病毒核心抗原(HCVcAg)检出情况的影响. 方法 收集2005年12月-2009年10月慢性丙型肝炎患者和HBV/HCV合并感染者资料,检测血清HCVcAg和HCV RNA,对后者血清进行HBV DNA、HBeAg检测,分析HCVcAg检出率与HBeAg、HBV DNA定量检测的关系.用独立两组多分类的X2检验方法进行统计学分析. 结果 共收集88例慢性丙型肝炎患者和62例HBV/HCV合并感染者资料,血清HCVcAg的检出率分别为72.7%(64/88)和38.7% (24/62),两者比较,x2= 17.358,P<0.01,差异有统计学意义.HCV RNA检出率分别为81.8% (72/88)和53.2% (33/62),两者比较,x2=20.110,P<0.01,差异有统计学意义.62例HBV/HCV合并感染者血清中,HBeAg阳性和HBeAg阴性感染者HCVcAg检出率分别为28.6% (12/42)和60.0% (12/20),两者比较,x2=5.641,P=0.011,差异有统计学意义.HCV RNA阳性率分别为42.9% (18/42)和80.0% (16/20),两者比较,X2=7.547,P< 0.01,差异有统计学意义.HBV DNA阳性和阴性时HCVcAg检出率分别为39.1% (18/46)和37.5% (6/16),两者比较,P>0.05,差异无统计学意义.与单纯HCV感染者血清HCVcAg检出率72.7% (64/88)比较,HBeAg阴性合并感染者为60.0% (12/20),x2=1.266,P=0.261,差异无统计学意义;HBV DNA阴性合并感染者为37.5% (6/16),x2=7.635,P<0.01,差异有统计学意义.结论 HBV/HCV合并感染时HCVcAg检出率较低,可能是由于HBeAg抑制HCV的复制,从而减少HCVcAg的表达所致. 相似文献
16.
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection 总被引:12,自引:0,他引:12
BACKGROUND & AIMS: Superinfection in patients with chronic hepatitis B virus (HBV) infection is not uncommon. Acute hepatitis delta virus (HDV) superinfection is associated with severe and/or progressive liver disease. The natural course following acute hepatitis C virus (HCV) superinfection has not been well studied. The aim of this study was to investigate the impact of acute HCV superinfection. METHODS: The clinical features during acute phase and long-term outcomes of acute HCV superinfection were studied and compared with a cohort of acute HDV superinfection and a matched control group of active chronic hepatitis B. RESULTS: Acute HCV superinfection typically occurs as acute icteric hepatitis. The severity is similar to acute HDV superinfection in that hepatic decompensation developed in 34% of patients, hepatitis failure occurred in 11%, and 10% died. During a follow-up period of 1-21 years, patients with acute HCV superinfection had a significantly higher cumulated incidence of cirrhosis (48% at 10 years) and hepatocellular carcinoma (14% at 10 years, 21% at 15 years, and 32% at 20 years) than acute HDV superinfection or active chronic hepatitis B. Hepatitis B surface antigen (HBsAg) seroclearance occurred earlier in HCV superinfected patients. Continuing hepatitis after HBsAg seroclearance was observed only in HCV superinfected patients. CONCLUSIONS: Acute HCV superinfection in patients with chronic HBV infection is clinically severe during its acute phase. The long-term prognosis following acute HCV superinfection is much worse than that following HDV superinfection or active hepatitis B in terms of continuing hepatitis activity after HBsAg loss and the development of cirrhosis or hepatocellular carcinoma. 相似文献
17.
EIJI TANAKA KENDO KIYOSAWA TAKESHI SEKI AKIHIRO MATSUMOTO TAKESHI SODEYAMA SEIICHI FURUTA TOSHIKO KUMAGAI MICHINORI KOHARA 《Journal of gastroenterology and hepatology》1993,8(5):442-447
Hepatitis C virus (HCV) antibodies were measured in 28 patients with auto-immune hepatitis type 1 using six different assay kits, three for C100–3 antibody and three for second generation HCV antibody, and two confirmatory tests to determine the prevalence of HCV infection in auto-immune hepatitis. These patients were confirmed to have human leucocyte antigen DR 4 or 2 which is susceptible to auto-immune hepatitis in Japanese. Of the 28 patients, four (14.3%) were positive for HCV antibody in all assays and reacted positively in at least one of the two confirmatory tests, indicating a true positive finding. Eight were positive for HCV antibody only by the Ortho ELISA kit and were negative in both confirmatory tests. The cut-off level for these results was low and became negative soon after the patients received corticosteroid treatment. Thus, these eight patients are presumed to be false-positive reactors. Hepatitis C virus RNA was detected in the serum of two of the four patients with HCV antibody and in none of 24 patients without HCV antibody. No significant difference was observed between the patients with and without HCV antibody in terms of clinical background, liver function tests and auto-antibodies. Our results showed that the prevalence of a past or present HCV infection in patients with auto-immune hepatitis in Japan is low; thus, auto-immune hepatitis is thought to be distinct from hepatitis type C. However, it is also suggested that HCV infection can potentially trigger auto-immune hepatitis. 相似文献
18.
HBV、HCV感染具有慢性化的流行特点。白细胞介素(IL)28B基因多态性与HBV、HCV感染慢性化及干扰素(IFN)抗病毒疗效具有相关性。简述了IL-28B生物学功能及特点,述评了IL-28B基因多态性与HCV感染的相关性,并归纳了目前发现的IL-28B基因多态性与HBV感染的相关性的众多研究报道。分析表明,IL-28B基因多态性与丙型肝炎病程转归及IFN抗病毒疗效的相关性研究报道较为一致;而IL-28B基因多态性与乙型肝炎病程转归,HBV感染后肝硬化、肝癌及IFN抗病毒疗效的相关性研究,各方学者均有不同的见解,尚需进一步的研究。 相似文献
19.
Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. 总被引:1,自引:0,他引:1
Seung Kew Yoon Joon Yeol Han Chul-Woo Pyo Jin Mo Yang Jeong Won Jang Chang Wook Kim U Im Chang Si Hyun Bae Jong Young Choi Kyu Won Chung Hee Sik Sun Hee Baeg Choi Tai-Gyu Kim 《Liver international》2005,25(6):1122-1127
BACKGROUND/AIM: Recent data have shown that the clinical outcome of hepatitis C virus (HCV) infection may be influenced by the host genetic factor. The aim of this study was to investigate whether particular human leukocytes antigen (HLA) molecules are associated with the susceptibility to HCV infection in the Korean population. METHODS: One hundred and thirty-seven patients with chronic HCV infection and 206 normal individuals were examined for HLA class I and II molecules. RESULTS: In class I antigens, the frequencies of HLA-A3 (relative risk (RR)=3.5, P<0.04), HLA-B35 (RR=2.0, P<0.03), and HLA-B46 (RR=2.5, P<0.02) significantly increased in chronic HCV carriers compared with the controls. The frequencies of DRB1*0803, DQB1*0601 and DQB1*0604 were significantly higher in chronic HCV carriers than in controls (RR=2.5, P<0.005; RR=1.8, P<0.05; RR=1.9, P<0.04, respectively). On the other hand, the frequencies of DRB1*0301, DQA1*0501 and DQB1*0201 were significantly lower in chronic HCV carriers than in normal controls (RR=0.2, P<0.03; RR=0.4, P<0.004; RR=0.5, P<0.02, respectively). The haplotype DRB1*0803-DQB1*0601 significantly increased (RR=2.5, P<0.02) while the DQA1*0501-DQB1*0201 significantly decreased (RR=0.2, P<0.03) in chronic HCV carriers compared with normal controls. In stratification analysis to investigate the interrelationships among the associated alleles, DRB1*0803 and DQB1*0601 were associated with HLA-B46, particularly in patients with chronic HCV carriers. CONCLUSIONS: These results suggest that particular HLA alleles may have an influence on chronic HCV infection as a host genetic factor in the Korean population. 相似文献
20.
Dr. Shinjiro Sato Shigetoshi Fujiyama MD Motohiko Tanaka MD Masafumi Goto MD Yuko Taura MD Shin-Ichi Kawano MD Tatsuo Sato MD Hiroyuki Yasuo MD 《Digestive diseases and sciences》1994,39(9):2022-2031
Antibody subclasses directed against the core protein (HCc) of hepatitis C virus (HCV) were measured in 27 patients with acute non-A, non-B (NANB) hepatitis, and 99 patients with chronic HCV-associated liver disease. IgM, IgA, and IgG anti-HCc responses were observed in 11 (40.7%), 7 (25.9%), and 18 (67%) patients with acute NANB hepatitis, respectively. Twenty-four (24.2%) and 40 (40.4%) patients with chronic HCV infection also had detectable IgM and IgA, respectively. IgM anti-HCc inconsistently detected acute infection, and HCV ribonucleic acid (RNA) could be detected preceding the rise in anti-HCc antibodies in five consecutive patients with acute hepatitis. IgM anti-HCc also could not distinguish acute from chronic infection and did not correlate with histologic progression. However, the form of IgA present (polymeric vs monomeric) did discriminate acute from chronic infection and the IgA anti-HCc titer correlated with histologic evidence of liver disease in patients with chronic HCV infection. 相似文献